Grace Therapeutics GRCE
NASDAQ GRCE
$2.18 +0.04 (+2.06%)
As of: Aug 21, 2026 · 12:30 PM EDT

Grace Therapeutics (GRCE) Change in Inventory (2020)

Grace Therapeutics (GRCE) posted Change in Inventory of $14000.0 for Q4 2020.

Grace Therapeutics (GRCE) Change in Inventory (2020) Analysis & Trends

Grace Therapeutics has reported Change in Inventory for 1 years, with the latest figure at $14000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn 27.70 Mn
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn 28.20 Mn
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn -
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn 132.00 Mn
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn 47.15 Mn
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn -280,000.00
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn 135.26 Mn
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn 12.97 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn - -
10 Grace Therapeutics 37.72 Mn 37.72 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 14,000.00
Dec 31, 2020 14,000.00